AGXT Antikörper (Middle Region)
Kurzübersicht für AGXT Antikörper (Middle Region) (ABIN452724)
Target
Alle AGXT Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- This antibody detects AGXT / AGT1 at Center.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human
-
Aufreinigung
- Purified through a protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide selected from the Center region of human AGXT
-
-
-
-
Applikationshinweise
-
Western blot: 1: 100 - 1: 500. ELISA: 1: 1,000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.
-
-
- AGXT (Alanine Glyoxylate Aminotransferase (AGXT))
-
Andere Bezeichnung
- AGXT / AGT1
-
Hintergrund
- AGXT is expressed only in the liver and protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification.Synonyms: SPAT, SPT, Serine-pyruvate aminotransferase
-
Molekulargewicht
- 43010 Da
-
Gen-ID
- 189
-
NCBI Accession
- NP_000021
-
UniProt
- P21549
-
Pathways
- Monocarboxylic Acid Catabolic Process, Dicarboxylic Acid Transport
Target
-